Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lateral Amyotrophic Sclerosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01091142
What this trial is testing

Single-Ascending-Dose Safety/Tolerability of NP001 in Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Neuraltus Pharmaceuticals, Inc. 56
Large-scale testing (Phase 3)Study completedNCT00349622
What this trial is testing

Clinical Trial Ceftriaxone in Subjects With ALS

Who this might be right for
Amyotrophic Lateral SclerosisALS
Massachusetts General Hospital 513
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07095686
What this trial is testing

Personalized Antisense Oligonucleotide for Participants With CHCHD10 ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
n-Lorem Foundation 9
Testing effectiveness (Phase 2)Study completedNCT03427086
What this trial is testing

Safety and Tolerability of High Dose Biotin in Patients With Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
American University of Beirut Medical Center 12
Not applicableStudy completedNCT02795897
What this trial is testing

Genomic Translation for Amyotrophic Lateral Sclerosis Care

Who this might be right for
ALS
Columbia University 254
Testing effectiveness (Phase 2)Study completedNCT01786174
What this trial is testing

Gilenya in Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Massachusetts General Hospital 30
Early research (Phase 1)Not Yet RecruitingNCT07093268
What this trial is testing

Safety of Intrathecal Riluzole in Patients With Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral SclerosisMotor Neuron Disease
Brain Trust Bio 10
Not applicableUnknownNCT06418646
What this trial is testing

Patients' and Caregivers' Views of Multidimensional Care in Amyotropic Lateral Sclerosis in Germany

Who this might be right for
Amyotrophic Lateral Sclerosis
Technische Universität Dresden 500
Early research (Phase 1)Active Not RecruitingNCT07204977
What this trial is testing

Acamprosate in C9orf72 Hexanucleotide Repeat Expansion Amyotrophic Lateral Sclerosis (ACALS)

Who this might be right for
Amyotrophic Lateral SclerosisMotor Neuron Disease
National Institute of Neurological Disorders and Stroke (NINDS) 30
Not applicableWithdrawnNCT03659422
What this trial is testing

Dietary Approach to Improving Quality of Life in Amyotrophic Lateral Sclerosis

Who this might be right for
Diet ModificationAmyotrophic Lateral Sclerosis
Terry L. Wahls
Testing effectiveness (Phase 2)Looking for participantsNCT06527222
What this trial is testing

Ranolazine in ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
Swathy Chandrashekhar, MBBS 72
Testing effectiveness (Phase 2)Ended earlyNCT03196375
What this trial is testing

Assess FLX-787 in Subjects With Motor Neuron Disease Experiencing Muscle Cramps.

Who this might be right for
Motor Neuron Disease
Flex Pharma, Inc. 54
Testing effectiveness (Phase 2)Study completedNCT01854294
What this trial is testing

GM604 Phase 2A Randomized Double-blind Placebo Controlled Pilot Trial in Amyotrophic Lateral Disease (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Genervon Biopharmaceuticals, LLC 12
Not applicableStudy completedNCT00714636
What this trial is testing

Cerebrospinal Fluid Repository

Who this might be right for
Amyotrophic Lateral SclerosisCerebrospinal FluidNeurodegenerative Disease+1 more
Drexel University College of Medicine 11
Not applicableLooking for participantsNCT05663008
What this trial is testing

Impairments of Neuro-muscular Communication in Motor-Neuron Disease: A Bio-Marker for Early and Personalised Diagnosis

Who this might be right for
ALS (Amyotrophic Lateral Sclerosis)Postpoliomyelitis SyndromeSpinal Muscular Atrophy
University of Dublin, Trinity College 400
Not applicableLooking for participantsNCT02795052
What this trial is testing

Neurologic Stem Cell Treatment Study

Who this might be right for
Neurologic DisordersNervous System DiseasesNeurodegenerative Diseases+23 more
MD Stem Cells 500
Early research (Phase 1)WithdrawnNCT01759784
What this trial is testing

Intraventricular Transplantation of Mesenchymal Stem Cell in Patients With ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
Royan Institute
Not applicableLooking for participantsNCT04097158
What this trial is testing

Biomarkers in Different Types of Amyotrophic Lateral Sclerosis (ALS) Patients Being Treated With Edaravone

Who this might be right for
Amyotrophic Lateral Sclerosis
Loma Linda University 160
Not applicableStudy completedNCT02574390
What this trial is testing

Answer ALS: Individualized Initiative for ALS Discovery

Who this might be right for
Amyotrophic Lateral SclerosisPrimary Lateral SclerosisFlail Arm ALS+5 more
Johns Hopkins University 1,049
Testing effectiveness (Phase 2)Study completedNCT00298597
What this trial is testing

Influence of G-CSF and EPO on Associative Learning and Motor Skills

Who this might be right for
Chronic StrokeAmyotrophic Lateral Sclerosis
University Hospital Muenster 180
Next Page